Beta Blockers for Atrial Fibrillation

Primary Indications for Beta Blockers in AF

Beta blockers are highly effective first-line agents for rate control in atrial fibrillation and should be used as the primary rate-control strategy in most patients, particularly those with high adrenergic states, heart failure, or post-operative AF 1, 2
The American Heart Association recommends beta blockers as the most effective drug class for achieving rate control targets, reaching specified heart rate endpoints in 70% of patients compared to 54% with calcium channel blockers 3, 2
Intravenous beta blockade effectively controls ventricular response in acute settings, particularly in high adrenergic states such as post-operative AF 3, 2
Nadolol and atenolol demonstrate the highest efficacy among beta blockers tested for rate control 3, 2
Atenolol, metoprolol, and sotalol provide superior control of exercise-induced tachycardia compared to digoxin 3, 4

The American College of Cardiology recommends beta blockers as mandatory for controlling ventricular rate in AF complicating thyrotoxicosis unless contraindicated 1
IV beta blockers are the recommended first-line agents to slow rapid ventricular response in ACS patients with AF who have no heart failure, hemodynamic instability, or bronchospasm 1
Beta blockers should be initiated cautiously in AF patients with heart failure and reduced ejection fraction, but remain indicated given their mortality benefit 3, 2
Carvedilol specifically lowers ventricular rate at rest and during exercise while reducing ventricular ectopy 3, 4
Combination therapy with digoxin and beta blockers is reasonable for controlling both resting and exercise heart rate in heart failure patients 1, 5

Esmolol: 500 mcg/kg IV over 1 minute loading dose, then 60-200 mcg/kg/min maintenance infusion (onset: 5 minutes) 6
Metoprolol: 2.5-5 mg IV bolus over 2 minutes, up to 3 doses (onset: 5 minutes) 6
Propranolol: 0.15 mg/kg IV (onset: 5 minutes) 6
Metoprolol: 25-100 mg twice daily (onset: 4-6 hours) 6
Propranolol: 80-240 mg daily in divided doses (onset: 60-90 minutes) 6
Atenolol: Effective for chronic rate control with once-daily dosing 3, 2

Combining digoxin with beta blockers is reasonable to control both resting and exercise heart rate, with careful dose titration to avoid bradycardia 1, 5
Beta blockers with or without digoxin achieved rate control endpoints more effectively than other drug classes in the AFFIRM study 3, 2

Wolff-Parkinson-White syndrome with pre-excited AF: Beta blockers can accelerate ventricular rate through the accessory pathway (Class III: Harm) 1
Active bronchospasm or severe asthma exacerbation 3, 6
Chronic obstructive pulmonary disease: Nondihydropyridine calcium channel antagonists are preferred over beta blockers (Class I recommendation) 1

Oral amiodarone may be considered for rate control when other measures are unsuccessful or contraindicated (Class IIb) 5
AV node ablation with permanent pacing is reasonable when pharmacological therapy is insufficient or not tolerated (Class IIa) 1, 5

Assess heart rate during both rest and exercise to ensure adequate control without excessive bradycardia 3, 6